People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CHF Solutions, Inc. | — | Biotechnology | Series A | $33.0M | $17.0M | 2016 |
| Cardialen, Inc. | — | Other Health Care | Series B | $28.2M | $71.8M | 2018 |
| SentiAR, Inc. | — | Other Health Care | Series A | $15.2M | $8.8M | 2022 |
Warren Watson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Warren Watson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| WILLIAM SCHMIDT | 2 | 7 |
| Paul Buckman | 1 | 10 |
| Jay Schmelter | 1 | 6 |
| Jon Salveson | 1 | 5 |
| David A. Rosa | 1 | 5 |
| John L. Erb | 1 | 5 |
| David Rosa | 1 | 5 |
| JEFFREY S. MATHIESEN | 1 | 4 |
| Gregory D. Waller | 1 | 4 |
| Thomas Thaler | 1 | 4 |
| JEFF PETERS | 1 | 4 |
| William Peters | 1 | 3 |
| ROBERT J. CALCATERRA | 1 | 3 |
| John Erb | 1 | 3 |
| Mark Harvey | 1 | 3 |
| Sean Churchill | 1 | 3 |
| Anna French | 1 | 3 |
| Paul A Buckman | 1 | 3 |
| ERIC A. GULVE | 1 | 2 |
| Geoffrey Brooke | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.